Loading…
Time Limited Exposure to a ROR1 Targeting Bispecific T Cell Engager (NVG-111) Leads to Durable Responses in Subjects with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)
Townsend, William, Leong, Sarah, Shah, Mittal, Batten, Toby, Tucker, David, Pottinger, Bryson, Paneesha, Shankaranarayana, El-Sharkawi, Dima, Eyre, Toby A., Lam, Ho Pui Jeff, Zheng, Jiexin, Cook, Sarah, Granger, David, Ahern, David, O'Donovan, Kieran, Nathwani, Amit C., Jasani, Parag
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Loading…
First-in-Human Phase I Trial of a ROR1 Targeting Bispecific T Cell Engager (NVG-111) in Combination with Ibrutinib or As Monotherapy in Subjects with Relapsed Refractory Chronic Lymphocytic Leukaemia (CLL) and Mantle Cell Lymphoma (MCL)
Townsend, William, Leong, Sarah, Tucker, David, Pottinger, Bryson, Paneesha, Shankara, El-Sharkawi, Dima, Eyre, Toby A., Batten, Toby, Shah, Mittal, Cook, Sarah, Granger, David, O'Donovan, Kieran, Nathwani, Amit C., Jasani, Parag
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Loading…
Loading…
T Cells From CLL Patients Recognize Spontaneously Peptides Derived of the Receptor Tyrosine Kinase Ror1
-Farsangi, Mohammad Hojjat, Daneshmanesh, Amir Hossein, Jeddi-Tehrani, Mahmood, Osterborg, Anders, Shokri, Fazel, Mellstedt, Håkan, Rabbani, Hodjattallah
Published in BLOOD (19.11.2010)
Published in BLOOD (19.11.2010)
Get full text
Journal Article
Publication
Loading…
ROR1 as a Therapeutic Target In E2A-PBX1-Positive Acute Lymphoblastic Leukemia
Bicocca, Vincent, Chang, Bill H, Muschen, Markus, Druker, Brian J, Tyner, Jeffrey W
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
Loading…
Loading…
Loading…
Loading…
ANTI-ROR1 ANTIBODIES AND USES THEREOF
Hoffstrom, Benjamin G, Riddell, Stanley R, Balakrishnan, Ashwini, Randolph-Habecker, Julie
Year of Publication 24.10.2024
Get full text
Year of Publication 24.10.2024
Patent
Loading…
Anti-ROR1 antibodies and uses thereof
Hoffstrom, Benjamin G, Riddell, Stanley R, Balakrishnan, Ashwini, Randolph-Habecker, Julie
Year of Publication 19.03.2024
Get full text
Year of Publication 19.03.2024
Patent
Loading…
Compositions and methods for treating cancer with anti-ROR1 immunotherapy
SCHNEIDER, Dina, DIMITROV, Dimiter S, ZHU, Zhongyu, DROPULIC, Boro, ORENTAS, Rimas J
Year of Publication 21.08.2025
Get full text
Year of Publication 21.08.2025
Patent
Loading…
ANTI-ROR1 ANTIBODIES AND USES THEREOF
Randolph-Habecker, , Julie, Hoffstrom, Benjamin G, Riddell, Stanley R, Balakrishnan, Ashwini
Year of Publication 01.06.2022
Get full text
Year of Publication 01.06.2022
Patent
Loading…
ANTI-ROR1 ANTIBODIES AND USES THEREOF
RANDOLPH-HABECKER, Julie, HOFFSTROM, Benjamin, G, BALAKRISHNAN, Ashwini, RIDDELL, Stanley, R
Year of Publication 08.12.2021
Get full text
Year of Publication 08.12.2021
Patent
Loading…
ANTI-ROR1 ANTIBODIES AND USES THEREOF
Hoffstrom, Benjamin G, Riddell, Stanley R, Balakrishnan, Ashwini, Randolph-Habecker, Julie
Year of Publication 20.05.2021
Get full text
Year of Publication 20.05.2021
Patent
Loading…
Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy
Orentas, Rimas J, Dropulic, Boro, Schneider, Dina, Dimitrov, Dimiter S, Zhu, Zhongyu
Year of Publication 08.12.2022
Get full text
Year of Publication 08.12.2022
Patent
Loading…
Anti-ROR1 antibodies and uses thereof
Hoffstrom, Benjamin G, Riddell, Stanley R, Balakrishnan, Ashwini, Randolph-Habecker, Julie
Year of Publication 06.04.2021
Get full text
Year of Publication 06.04.2021
Patent
Loading…
Loading…
Loading…
Compositions and methods for treating cancer with anti-ROR1 immunotherapy
Year of Publication 27.09.2022
Get full text
Patent
Loading…
Compositions and methods for treating cancer with anti-ROR1 immunotherapy
Orentas, Rimas J, Dropulic, Boro, Schneider, Dina, Dimitrov, Dimiter S, Zhu, Zhongyu
Year of Publication 27.09.2022
Get full text
Year of Publication 27.09.2022
Patent